Loading...
ROCO
6569
Market cap110mUSD
Jul 09, Last price  
106.50TWD
1D
0.95%
1Q
5.97%
Jan 2017
-3.95%
IPO
-3.95%
Name

Onyx Healthcare Inc

Chart & Performance

D1W1MN
ROCO:6569 chart
P/E
31.71
P/S
2.70
EPS
3.36
Div Yield, %
3.72%
Shrs. gr., 5y
1.81%
Rev. gr., 5y
-0.51%
Revenues
1.31b
+5.80%
1,482,944,0001,347,304,0001,201,760,0001,600,265,0001,492,860,0001,241,251,0001,313,288,000
Net income
112m
-38.26%
239,377,000167,075,000127,551,000202,963,000255,262,000180,914,000111,701,000
CFO
164m
+31.84%
376,453,000191,106,00017,128,000161,791,000350,493,000124,516,000164,157,000
Dividend
Jul 03, 20253.96063 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Onyx Healthcare Inc. is a dedicated Taiwanese firm specializing in medical information technology. The company focuses on the entire lifecycle—from conceptual design and manufacturing to the commercial distribution—of medical computing hardware and peripherals, primarily targeting the hospital and clinical IT markets within Taiwan. Their extensive product lineup encompasses a variety of advanced solutions, such as AI-enabled medical PCs and tablets, specialized computer and monitor setups for digital operating rooms and telemedicine, and adaptable medical cart computers. They also offer robust medical power panel PCs, power banks, and sophisticated battery management systems. Further offerings include portable medical tablets, professional slim and powerful all-in-one PCs, medical displays and integrated computing solutions for medical devices, as well as motherboards and industrial-grade PCs and tablets, alongside healthcare infotainment systems. In addition to their core products, Onyx Healthcare provides custom Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) services. Established in 2010, the company is headquartered in New Taipei City, Taiwan, and operates as a subsidiary of AAEON Technology Inc.
IPO date
Dec 21, 2016
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT